ZERONA® Laser Proves a Success in Munich

ZERONA® Laser Proves a Success in Munich

Documents
2 pages
Lire
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

Description

ZERONA® Laser Proves a Success in Munich PR Newswire ABINGDON, England, July 25, 2012 ABINGDON, England, July 25, 2012 /PRNewswire/ -- Initial reports from Munich highlight positive results with the ZERONA laser ®Trials of the non-invasive ZERONA laser, manufactured by ERCHONIA in Munich, Germany, have demonstrated the significant body

Sujets

Informations

Publié par
Nombre de lectures 20
Langue English
Signaler un problème
ZERONA® Laser Proves a Success in Munich
PR Newswire ABINGDON, England, July 25, 2012
ABINGDON,England,July 25, 2012/PRNewswire/ --Initial reports from Munich highlight positive results with the ZERONA laser ® Trials of the non-invasive ZERONAlaser, manufactured by ERCHONIA in Munich, Germany, have demonstrated the significant body sculpting benefits of Low Level Laser Technology (LLLT), according to leading dermatologist Dr Patricia Ogilvie. "The ZERONA laser has a photochemical action, working on the parts of the body where fat is stored, and has been FDA-cleared for the non-invasive circumferential reduction of the waist, hips and thighs since 2010."
The ZERONA's cold laser technology uses low energy lasers to release fat from cells without destroying them, and this therapeutic approach delivers noticeable body contouring results without elevating cholesterol or triglyceride levels. Dr Ogilvie described the treatment: "In a series of 20 minute sessions, a laser beam is directed at the body at waist level on both the patient's front and back. After treatment, the fatty material drains into the lymphatic system and is removed naturally by the body. As a result, adjacent areas are also slimmed down and it is possible to achieve reductions in circumference of more than 10 cm; tissue also appears significantly firmer afterwards." She added: "The procedure is totally painless - the patient feels absolutely nothing during treatment - and there are no risks involved." James Stringer, Vice President, European Sales, at Primcogent Solutions, commented: "We are delighted that Dr Ogilvie is having success with the ZERONA laser and look forward to seeing the results from the trials she will be undertaking." Since these trials began, ERCHONIA has released the complementary ZERONA AD, which received US FDA clearance for the safe and effective reduction of upper arm circumference inMay 2012. For more information, visit http://www.primcogent.com. About Primcogent Solutions Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical and convincing scientific and clinical foundation. Primcogent Solutions' signature product, ZERONA, manufactured by Erchonia Medical, is the only platform that is CE-marked and FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist and thighs. Primcogent Solutions' revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with
purchasing capital equipment. For more information, visit http://www.primcogent.com. About Erchonia Erchonia is the global leader in low-level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world's leading physicians to advance the science of low-level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently, thousands of Erchonia's lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit http://www.erchonia.com. For more information, contact Primcogent Solutions, 20 Milton Park Abingdon Oxon OX14 4SH Tel: +44(0)1235-841590 Email: sales@primcogent.com http://www.primcogent.com
© 2012kdm communications limited